Simpson Thacher represented Gordon Dyal & Co. in the transaction, while Davis Polk and Plesner advised Novozymes. Kromann Reumert has advised Novo Holdings and the Novo…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
